Ulf Brüggemeier

This inventor holds 14 USPTO granted patents and 13 published patent applications and 7 EPO patents. Top assignees: Bayer Healthcare Aktiengesellschaft, Bayer Pharma Aktiengesellschaft, Bayer Schering Pharma Ag. Active years: 1998-2014.

USPTO Granted Patents = 14 (Patent Applications = 13)

% Patents Active = 14.3

EPO Patents = 7 (Patent Applications = 4)

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 58(Granted Patents)

Company Filing History:

3 out of 77

Bayer Healthcare Aktiengesellschaft

patents

3 out of 386

Bayer Pharma Aktiengesellschaft

patents

3 out of 192

Bayer Schering Pharma Ag

patents

4. 2 out of 12,266

Bayer Aktiengesellschaft

patents

5. 2 out of 721

Bayer Intellectual Property Gmbh

patents

6. 1 out of 754

Siemens Healthcare Diagnostics Gmbh

patents

Years Active: 1998-2014

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8859601 - Substituted benzyl and phenylsulfonyl triazolones, and use thereof (2014-10-14),

2. 8796324 - Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof (2014-08-05),

3. 8343745 - Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof (2013-01-01),

4. 8252525 - Diagnostics and therapeutics for diseases associated with G-protein coupled receptor AdipoR1(AdipoR1) (2012-08-28),

5. 8202895 - Substituted 2-acetamido-5-aryl-1,2,4-triazolones and use thereof (2012-06-19),

6. 8088584 - LTBP2 as a biomarker and diagnostic target (2012-01-03),

7. 8084481 - Substituted arylimidazolone and triazolone as inhibitors of vasopressin receptors (2011-12-27),

8. 7803593 - Acylglycerol acyltransferase-like protein MGAT-X1 and uses thereof (2010-09-28),

9. 7776922 - Substituted [(phenylethanoyl)amino]benzamides (2010-08-17),

10. 7491550 - Diagnostics and therapeutics for diseases associated with Neuromedin U2 receptor (NMU2) (2009-02-17),

11. 7465548 - Methods of screening for potential therapeutics for diseases associated with G-protein coupled receptor HM74a (2008-12-16),

12. 7338781 - Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof (2008-03-04),

13. 7220824 - Integrin-mediated drug targeting (2007-05-22),

14. 5723031 - Method for the analytical separation of viruses (1998-03-03),

Title: Inventor Ulf Brüggemeier

Introduction: Ulf Brüggemeier is a renowned inventor hailing from Leichlingen, Germany, known for his groundbreaking contributions to various fields.

Latest Patents: Ulf Brüggemeier holds several patents in the areas of renewable energy technologies, sustainable materials, and innovative manufacturing processes.

Career Highlights: With a career spanning over two decades, Ulf Brüggemeier has worked with leading research institutions and companies to develop cutting-edge solutions that have had a significant impact on the industry.

Collaborations: Throughout his career, Ulf Brüggemeier has collaborated with top scientists, engineers, and inventors from around the world, fostering a culture of innovation and excellence.

Conclusion: Ulf Brüggemeier's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and researchers.